Do alcohol-metabolism genes explain why two people respond differently to drinking? They can help explain differences in enzyme activity and acetaldehyde exposure, but a genotype cannot by itself determine a person’s blood alcohol concentration (BAC) or reconstruct intoxication at an earlier time. In forensic toxicology, genetic variation is one biological consideration—not a replacement for dose, timing, absorption, and laboratory evidence.
Alcohol dehydrogenase (ADH) converts ethanol to acetaldehyde. Aldehyde dehydrogenase (ALDH) then converts acetaldehyde to acetate. Acetaldehyde is biologically active and potentially harmful. The rate of its production and clearance can therefore influence a person’s physiological response to alcohol.
In their 2012 scientific review, Hurley and Edenberg described multiple ADH and ALDH enzymes and functionally important variants in the genes that encode them. The review emphasizes that a small genetic change can alter an enzyme’s kinetic properties. It does not establish a universal BAC conversion rule for each genotype.
Some ADH1B variants increase the rate at which ethanol is converted to acetaldehyde. A well-described ALDH2 variant reduces the ability to clear acetaldehyde efficiently. Both pathways can increase acetaldehyde exposure under relevant conditions. This helps explain why certain inherited variants are associated with uncomfortable reactions to drinking and differences in alcohol-consumption patterns and alcohol-use-disorder risk.
Association with drinking behavior, however, is not the same as proof of a particular concentration. A genotype may have measurable biological consequences while an individual’s observed BAC remains dependent on what and when they drank, how ethanol entered the circulation, distribution, and elimination.
A forensic reconstruction requires more than a plausible metabolic mechanism. It requires an event timeline, reliable specimen collection time, validated analysis, and defensible pharmacokinetic assumptions. A later BAC is a measurement at the sampling time; estimating an earlier concentration is an inference. Inferring an unmeasured person’s genotype from apparent intoxication or behavior is an additional, unsupported step.
David Levitt’s physiologically based pharmacokinetic modeling paper provides an independent illustration of the complexity. In model analyses of previously published human ethanol data, absorption after alcohol consumed with a meal was markedly slower than fasting absorption; the modeled rate was governed largely by gastric emptying. The study also discussed the pitfalls of conventional first-pass metabolism calculations when kinetics are nonlinear. Those findings concern absorption and modeling rather than inherited enzyme variants, but they reinforce the point that BAC cannot be reduced to a single metabolic variable.
Genetic mechanism: Whether a verified variant changes the activity of a relevant enzyme. Physiological effect: Whether the variant plausibly alters ethanol or acetaldehyde handling under the documented conditions. Analytical evidence: What alcohol concentration was actually measured in which specimen, using which method, at what time. Historical inference: Whether an earlier BAC can reasonably be estimated given the assumptions and uncertainty.
These questions should not be collapsed. Even a confirmed genotype and a reliable ethanol test do not automatically establish the amount consumed, a precise earlier BAC, or the person’s behavior at a disputed moment.
Not as a general rule. Some ALDH2 variants affect acetaldehyde clearance; that is not identical to directly predicting BAC. Dose, absorption, distribution, and other physiology still matter.
Yes. Variants that change acetaldehyde production or clearance can alter physiological responses and are associated with differences in drinking patterns. The effect should not be generalized to everyone.
No. Genotype is not a stand-alone historical BAC calculator. A reconstruction needs case-specific facts and an uncertainty-aware pharmacokinetic assessment.
Hurley TD, Edenberg HJ. Genes Encoding Enzymes Involved in Ethanol Metabolism. Alcohol Research: Current Reviews. 2012;34(3):339–344. Read the research.
Levitt DG. PKQuest: Measurement of Intestinal Absorption and First Pass Metabolism—Application to Human Ethanol Pharmacokinetics. BMC Clinical Pharmacology. 2002;2:4. doi:10.1186/1472-6904-2-4.
For the separate distinction between a specimen BAC and ethanol exposure in the brain, see Blood Alcohol Is Not Brain Alcohol. For absorption and gastric emptying, see Alcohol Absorption Is Not a Straight Line.
General scientific information, not an opinion about any individual case.